female infertility. Female infertility
Conditions
Interventions
Intervention 1: Intervention group: Includes 30 patients aged between 20-45 years who refer to hospitals of Islamic Azad University of Tehran and are diagnosed with apathy. After reviewing the study's
Sponsors
Islamic Azad University
Eligibility
Sex/Gender
Female
Age
20 Years to 45 Years
Inclusion criteria
Inclusion criteria: Infertile women aged 20 to 45
Exclusion criteria
Exclusion criteria: Underlying conditions such as diabetes, high blood pressure, high cholesterol. Individuals with neurological or psychiatric disorders. individuals with high prolactin levels. individuals with a history of recurrent miscarriage.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Follicle size (diameter). Timepoint: Before the start of the intervention and 8 weeks after the end of the intervention. Method of measurement: Ultrasound.;Number of follicles. Timepoint: Before the start of the intervention and 8 weeks after the end of the intervention. Method of measurement: Ultrasound.;Number of matured follicles. Timepoint: Before the start of the intervention and 8 weeks after the end of the intervention. Method of measurement: Ultrasound.;Pregnancy chance. Timepoint: Before the start of the intervention and 8 weeks after the end of the intervention. Method of measurement: Blood test (B-hcg test) and ultrasound.;BHCG test. Timepoint: Before the start of the intervention and 8 weeks after the end of the intervention. Method of measurement: Blood test (BHCG test). | — |
Secondary
| Measure | Time frame |
|---|---|
| Fetal heart rate FHR. Timepoint: 8 weeks after the end of the intervention. Method of measurement: Ultrasound.;Miscarriage rate. Timepoint: 8 weeks after the end of the intervention. Method of measurement: Ultrasound and patient interview.;Luteinizing hormone [LH]. Timepoint: Before the intervention and 8 weeks after the completion of the intervention. Method of measurement: Blood test (measurement of LH hormone by immunoassay method).;Follicle-stimulating hormone [FSH]. Timepoint: Before the intervention and 8 weeks after the completion of the intervention. Method of measurement: Blood test (FSH hormone measurement by immunoassay method).;Estrogen. Timepoint: Before the intervention and 8 weeks after the completion of the intervention. Method of measurement: Blood test (estrogen measurement by immunoassay).;Testosterone. Timepoint: Before the intervention and 8 weeks after the completion of the intervention. Method of measurement: Blood test (Testosterone measurement by immunoassay).;Androstenedione. Timepoint: Before the intervention and 8 weeks after the completion of the intervention. Method of measurement: Blood test (measurement of androstenedione by immunoassay).;Ovary size. Timepoint: Before the intervention and 8 weeks after the completion of the intervention. Method of measurement: Ultrasound. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Maryam Shiehmorteza
Islamic Azad University
Outcome results
None listed